Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)
Press Releases about Protalix BioTherapeutics, Inc. (DE) Common Stock
Protalix BioTherapeutics to Present at Investor Summit Virtual
September 11, 2025
Via ACCESS Newswire
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via TheNewswire.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>